FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079429 [Registered on: 24/01/2025] Trial Registered Prospectively
Last Modified On: 22/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Incidence of pruritus among different types of surgeries after injecting morphine in spinal anaesthesia 
Scientific Title of Study   EFFECT OF TYPE OF SURGERY ON THE INCIDENCE OF PRURITUS FOLLOWING 100 mcg INTRATHECAL MORPHINE IN ADULTS AN OBSERVATIONAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ajay Nalluri 
Designation  Post Graduate Resident  
Affiliation  JSS medical College and Hospital 
Address  Dept of Anaesthesiology Critical care JSS Hospital Mahatma Gandhi Road Mysuru

Mysore
KARNATAKA
570004
India 
Phone  8121528565  
Fax    
Email  ajay.nalluri.7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Sarika M Shetty 
Designation  Associate Professor 
Affiliation  JSS medical College and Hospital 
Address  Dept of Anaesthesiology Critical care JSS Hospital Mahatma Gandhi Road Mysuru

Mysore
KARNATAKA
570004
India 
Phone  8121528565  
Fax    
Email  drsarikamshetty@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Ajay Nalluri 
Designation  Post Graduate Resident  
Affiliation  JSS medical College and Hospital 
Address  Dept of Anaesthesiology Critical care JSS Hospital Mahatma Gandhi Road Mysuru


KARNATAKA
570004
India 
Phone  8121528565  
Fax    
Email  ajay.nalluri.7@gmail.com  
 
Source of Monetary or Material Support  
JSS academy of higher education, Bannimantap, Mysuru 570015 
 
Primary Sponsor  
Name  JSS academy of higher education 
Address  JSSAHER,JSS MEDICAL CAMPUS,S.S NAGAR, BANNIMANTAP,MYSURU 570015 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AJAY NALLURI  JSS HOSPITAL   operation theatre complex,3rd floor, JSS hospital
Mysore
KARNATAKA 
8121528565

ajay.nalluri.7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  intrathecal morphine  100mcg intrathecal morphine to the patients recieving spinal injection 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged between 20-60 years who are scheduled for below umbilical
surgeries i.e, patients posted for gynaecological surgeries, orthopaedic and general surgeries
belonging to American Society of Anaesthesiologists Physical Status (ASA-PS) class I & II
under spinal anaesthesia will be included in the study 
 
ExclusionCriteria 
Details  Patients aged less than 20 years and more than 60 years with ASA grading gretaer than or equal to 3, and surgeries with spinal anaesthesia converted to general anaesthesia,BMI gretaer than 30 , patients with prior history of itching and other dermatalogical disorders are excluded from the study 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
pruritus followed by intra thecal administration of morphine  from sub archanoid block to 24 hours post operative monitoring. 
 
Secondary Outcome  
Outcome  TimePoints 
nause and vomiting followed by intra thecal administration of morphine  from sub archanoid block to 24 hours post operative monitoring. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Patients will be evaluated thoroughly as a part of the pre anaesthetic evaluation. Thorough
airway assessment, relevant investigations will be checked and the vitals will be
recorded.Patients assessed for the study eligibility & Patients meeting the criteria are
selected, shifted to the operating room. All subjects under study will receive Inj
BUPIVACAINE 15mg + Inj MORPHINE 100 mcg intrathecally. Post surgery patients are
shifted to the recovery room , followed for 24 hours and signs of pruritus, nausea & vomiting are noted by the
recovery room clinician and graded according to the pruritus grading system.
 
Close